IOMED® Iontophoresis

The Company was incorporated in Utah in 1974 as Motion Control, Inc. In 1987, the Company merged with JMW Acquisition Corporation, and the name of the merged entity was changed to IOMED, Inc.

Today, IOMED is a leader in developing, manufacturing and marketing active drug delivery systems in the physical and occupational therapy and sports medicine markets. We are pursuing opportunities to advance our position as a provider of quality, innovative medical products that improve patient healthcare.

In addition, we are seeking collaborative opportunities to develop non-invasive drug delivery technology to satisfy unmet medical needs. We have proprietary iontophoresis technology in various stages of research and product development primarily for transdermal drug delivery and for the treatment of ophthalmic disease.

IOMED, Inc. adheres to the principles of Quality, Integrity, and Service.

Quality - We are committed to developing, producing and providing high quality medical products and services that meet or exceed the needs of our customers.

Integrity - We will provide a work environment where open and honest communication fosters teamwork and timely problem resolution.

Service - We are committed to achieving and maintaining a high level of internal and external customer service by continuously striving for excellence.